— Know what they know.
Not Investment Advice

DHI vs PHM vs LEN

161 measures in 16 categories, one definition each, computed from filings and market data.
DHI51.7
D.R. Horton, Inc.
Consumer Cyclical · Residential Construction
$139.39 −0.11%$39.0B mkt cap
Score DNA
PHM48.0
PulteGroup, Inc.
Consumer Cyclical · Residential Construction
$113.55 +0.50%$21.6B mkt cap
Score DNA
LEN39.8
Lennar Corporation
Consumer Cyclical · Residential Construction
$77.08 −0.79%$18.3B mkt cap
Score DNA

Price, rebased to 100 three years ago

DHI   PHM   LEN   · weekly adjusted closes
100150200Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26PHM 159DHI 139LEN 74
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureDHIPHMLEN
Insider open-market buys, 180d 0 0 45
Insider $ bought, 180d — — $595.29M
Congress purchases, 180d 2 1 2
Last Congress purchase 2026-09-25 2026-09-11 2026-08-10
13F net change in holders +89 +10 +1
ETFs adding shares, 30d 1,134 1,060 768
ETFs trimming, 30d 1,066 952 762
Net ETF funds, 30d +68 +108 +6

Valuation

16 measures
MeasureDHIPHMLEN
P/E (TTM) 12.8x
50th
11.3x
22nd
14.0x
61st
PEG (P/E ÷ 3-yr EPS CAGR) — — —
Price / sales 1.2x
63rd
1.3x
68th
0.6x
26th
Price / book 1.6x
68th
1.7x
74th
0.9x
37th
Price / tangible book 2.0x
78th
2.1x
83rd
1.1x
39th
Price / free cash flow 11.8x
24th
14.3x
35th
20.2x
71st
Price / operating cash flow 11.6x
28th
13.3x
39th
17.6x
67th
Enterprise value $44.1B
100th
$22.0B
95th
$21.5B
84th
EV / sales 1.3x
58th
1.3x
68th
0.7x
11th
EV / EBITDA 10.7x
56th
9.1x
28th
10.7x
50th
EV / EBIT 11.0x
44th
9.5x
17th
11.3x
50th
EV / free cash flow 13.3x
18th
14.6x
29th
23.7x
71st
Earnings yield 7.8%
53rd
8.8%
79th
7.2%
42nd
FCF yield 8.5%
79th
7.0%
68th
5.0%
37th
Operating cash flow yield 8.6%
74th
7.5%
63rd
5.7%
37th
Graham number (per share) $140.26
78th
$121.88
72nd
$106.09
61st

Profitability (TTM)

12 measures
MeasureDHIPHMLEN
Gross margin 22.6%
53rd
24.5%
68th
9.5%
0th
EBITDA margin 12.3%
68th
14.8%
74th
6.3%
37th
Operating margin 11.6%
58th
14.6%
74th
5.3%
26th
EBIT margin 12.0%
68th
14.1%
79th
5.9%
37th
Net margin 9.2%
74th
11.6%
84th
4.1%
32nd
NOPAT margin 8.8%
58th
11.2%
74th
4.0%
21st
FCF margin 9.9%
74th
9.2%
68th
2.8%
26th
Operating cash flow margin 10.1%
74th
9.9%
68th
3.3%
26th
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 11.2%
37th
7.1%
11th
4.1%
0th
Stock comp / revenue 0.3%
22nd
0.4%
33rd
0.4%
56th
Effective tax rate 24.6%
74th
23.6%
58th
25.8%
89th

Returns on capital

11 measures
MeasureDHIPHMLEN
ROE (on average equity) 12.8%
68th
14.9%
79th
5.9%
32nd
ROA 8.4%
63rd
10.6%
79th
3.8%
32nd
ROIC 10.1%
53rd
13.6%
63rd
5.1%
26th
ROCE 12.1%
63rd
15.1%
74th
6.0%
37th
Return on tangible assets 11.0%
68th
12.9%
79th
5.6%
37th
Cash ROIC (OCF / invested capital) 11.6%
68th
12.1%
74th
4.2%
32nd
Gross profitability (GP / assets) 20.7%
58th
22.0%
63rd
9.1%
11th
ROIC, 3-yr average 11.4%
53rd
16.1%
68th
7.4%
21st
ROIC, 5-yr average 17.9%
63rd
22.7%
79th
11.5%
21st
ROE, 5-yr average 20.6%
63rd
23.8%
74th
13.6%
16th
Incremental ROIC 17.5%
58th
-42.9%
26th
30.5%
68th

Growth

17 measures
MeasureDHIPHMLEN
Revenue growth (TTM YoY) -3.5%
74th
-7.3%
63rd
-8.1%
53rd
Revenue growth (QoQ) 22.1%
74th
16.9%
53rd
1.3%
0th
Revenue CAGR, 3 yr -1.2%
42nd
-0.8%
47th
-1.5%
32nd
Revenue CAGR, 5 yr 5.1%
63rd
6.0%
74th
4.6%
53rd
Gross profit CAGR, 3 yr -7.1%
32nd
-6.9%
47th
-27.5%
0th
Operating income CAGR, 3 yr -15.0%
44th
-12.7%
56th
-31.7%
17th
Net income growth (TTM YoY) -23.0%
67th
-30.5%
56th
-51.1%
28th
Net income CAGR, 3 yr -14.4%
56th
-11.6%
67th
-30.5%
17th
EPS growth (TTM YoY) -20.6%
61st
-28.0%
56th
-47.5%
28th
EPS CAGR, 3 yr -9.4%
61st
-7.4%
67th
-26.3%
17th
EPS CAGR, 5 yr 1.0%
44th
9.2%
67th
-16.3%
17th
FCF growth (TTM YoY) 18.2%
46th
14.8%
38th
—
FCF CAGR, 3 yr 0.7%
93rd
-7.7%
87th
-44.2%
20th
Operating cash flow CAGR, 3 yr -0.3%
94th
-6.9%
88th
-41.9%
25th
Book value CAGR, 3 yr 9.3%
47th
15.6%
79th
-0.0%
5th
Dividend CAGR, 3 yr 8.3%
92nd
7.9%
83rd
3.5%
33rd
Sustainable growth rate 10.6%
61st
13.4%
78th
3.7%
17th

Margin history & stability

7 measures
MeasureDHIPHMLEN
Gross margin, 3-yr average 24.6%
63rd
27.3%
84th
17.5%
11th
Operating margin, 3-yr average 14.4%
74th
18.6%
89th
9.9%
47th
Net margin, 3-yr average 11.3%
74th
14.6%
89th
7.8%
42nd
FCF margin, 3-yr average 7.9%
68th
8.1%
74th
3.8%
32nd
Revenue stability (0-1) 0.44
53rd
0.61
58th
0.42
32nd
Earnings stability (0-1) 0.19
32nd
0.09
26th
0.70
84th
Margin stability (0-1) 0.92
84th
0.92
74th
0.68
0th

Liquidity (latest quarter)

7 measures
MeasureDHIPHMLEN
Cash & short-term investments $2.1B
100th
$1.9B
95th
$1.2B
79th
Net cash (− = net debt) −$5.1B
0th
−$412.8M
63rd
−$3.1B
5th
Working capital $31.6B
100th
$12.7B
84th
$13.3B
89th
Current ratio 9.84
84th
5.27
53rd
8.38
74th
Quick ratio 2.37
84th
0.65
32nd
1.17
47th
Cash ratio (cash + ST investments / current liabilities) 0.58
47th
0.63
53rd
0.64
58th
Defensive interval (days) 249 days
16th
427 days
53rd
568 days
74th

Leverage & solvency (latest quarter)

13 measures
MeasureDHIPHMLEN
Total debt $7.2B
100th
$2.3B
79th
$4.3B
89th
Debt / equity 0.30
37th
0.18
21st
0.20
26th
Net debt / equity 0.21
53rd
0.03
21st
0.15
37th
Debt / assets 19.7%
47th
12.6%
21st
12.9%
26th
Debt / capital 23.2%
37th
15.0%
21st
16.6%
26th
Debt / EBITDA 1.75
44th
0.95
28th
2.14
56th
Net debt / EBITDA 1.24
50th
0.17
22nd
1.57
56th
Interest coverage (EBIT / interest) 43.7x
58th
4,619.9x
100th
16.6x
33rd
Cash interest coverage 36.7x
50th
3,245.5x
100th
9.1x
33rd
Debt payback (years of OCF) 2.1 yrs
29th
1.4 yrs
24th
4.1 yrs
47th
Liabilities / assets 33.2%
32nd
28.7%
21st
35.0%
42nd
IS credit model rating AAA AAA AA
Implied credit spread (bps) 50
0th
50
0th
80
32nd

Efficiency

11 measures
MeasureDHIPHMLEN
Asset turnover 0.91
47th
0.92
53rd
0.94
58th
Fixed asset turnover 496.28
100th
— —
Inventory turnover 1.0
42nd
0.9
37th
2.2
74th
Receivables turnover 251.7
100th
— 25.8
35th
Days sales outstanding 1 days
11th
0 days
0th
14 days
63rd
Days inventory outstanding 378 days
58th
397 days
63rd
168 days
21st
Days payables outstanding 20 days
37th
21 days
53rd
21 days
42nd
Cash conversion cycle (days) 360 days
58th
375 days
63rd
161 days
26th
Capex / revenue 0.1%
5th
0.7%
53rd
0.4%
26th
Capex / depreciation 0.39
16th
1.01
42nd
1.29
58th
Operating expense ratio 10.0%
21st
9.6%
11th
10.8%
32nd

Cash flow & earnings quality

7 measures
MeasureDHIPHMLEN
Operating cash flow / net income 1.10
67th
0.85
44th
0.79
33rd
FCF / net income 1.08
67th
0.79
50th
0.69
33rd
FCF / operating cash flow 98.7%
94th
93.0%
65th
87.1%
29th
Capex / operating cash flow 1.3%
6th
7.0%
35th
12.9%
65th
Accruals ratio -0.8%
32nd
1.6%
74th
0.8%
53rd
Sloan accruals ratio -4.0%
42nd
-0.4%
47th
-0.2%
53rd
Earnings quality score (0-1) 1.00
89th
0.75
44th
0.50
22nd

Dividends & buybacks

9 measures
MeasureDHIPHMLEN
Dividend yield 1.3%
68th
0.9%
63rd
2.6%
89th
Dividend per share (TTM) $1.80
79th
$1.04
68th
$2.00
89th
Payout ratio (dividends / net income) 16.6%
56th
9.9%
50th
37.6%
83rd
Dividends / FCF 15.3%
65th
12.5%
59th
54.2%
76th
Dividend growth (YoY) 10.2%
67th
12.8%
83rd
0.1%
33rd
Buyback yield 7.5%
84th
6.1%
63rd
5.4%
53rd
Shareholder yield (dividends + buybacks) 8.8%
74th
7.0%
53rd
8.1%
68th
Share count change (YoY) -3.0%
74th
-3.4%
58th
-7.0%
26th
Buybacks, last 5 years $13.1B
100th
$6.3B
95th
$848.0M
68th

Scores & forensic checks

15 measures
MeasureDHIPHMLEN
IS score 52
79th
48
68th
40
42nd
IS profitability 41
63rd
45
79th
20
32nd
IS growth 20
63rd
16
53rd
14
37th
IS value 69
37th
79
47th
79
58th
IS momentum 49
79th
38
47th
36
32nd
IS risk (safety) 100
53rd
100
53rd
90
37th
IS quality 68
84th
61
63rd
56
42nd
IS balance sheet 74
53rd
86
79th
71
37th
IS earnings quality 93
95th
86
68th
83
47th
IS cash flow 62
74th
58
63rd
42
32nd
Piotroski F-score (0-9) 5
58th
3
0th
5
58th
Altman Z-score 5.9
68th
5.9
74th
3.6
42nd
Beneish M-score −2.50
47th
−2.33
58th
−2.79
16th
Ohlson O-score −11.09
5th
−10.90
11th
−9.71
47th
IS credit score 96
74th
96
79th
86
47th

Per share

7 measures
MeasureDHIPHMLEN
EPS, diluted (TTM) $10.59
79th
$9.83
74th
$5.52
53rd
Book value per share $82.59
47th
$67.13
37th
$90.68
63rd
Tangible book per share $84.20
58th
$67.55
37th
$76.78
47th
Revenue per share $115.64
58th
$84.64
42nd
$134.48
63rd
FCF per share $11.47
79th
$7.80
68th
$3.82
37th
Operating cash flow per share $11.62
74th
$8.39
68th
$4.38
37th
Cash per share $7.21
47th
$9.73
53rd
$4.84
37th

Size (TTM)

8 measures
MeasureDHIPHMLEN
Market cap $39.0B
100th
$21.6B
95th
$18.3B
84th
Revenue $33.3B
100th
$16.4B
84th
$32.0B
89th
EBITDA $4.1B
100th
$2.4B
95th
$2.0B
84th
Net income $3.1B
100th
$1.9B
95th
$1.3B
84th
Free cash flow $3.3B
100th
$1.5B
95th
$908.2M
74th
Total assets $36.5B
100th
$18.3B
84th
$33.4B
89th
Shareholders' equity $23.8B
100th
$13.0B
84th
$21.6B
89th
Employees 14,341
100th
6,506
68th
12,532
89th

Price performance

9 measures
MeasureDHIPHMLEN
1 day −0.1% +0.5% −0.8%
1 week +3.3% +1.3% +0.5%
1 month −0.7% −4.5% −2.7%
3 months −3.4% −7.6% −6.4%
6 months −6.4% −9.9% −15.4%
Year to date −3.5% −4.0% −24.4%
1 year −9.1% −8.2% −35.6%
3 years, cumulative +32.3% +53.8% −29.0%
5 years, cumulative +76.1% +151.6% −10.6%

Technicals

4 measures
MeasureDHIPHMLEN
RSI 14 52.1 43.9 46.6
From 52-week high −18.1% −20.9% −41.1%
From 52-week low +6.9% +6.0% +7.4%
Beta 1.35 1.16 1.38
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms